Literature DB >> 10454061

One hundred years of adrenaline: the discovery of autoreceptors.

M R Bennett1.   

Abstract

The active principle of suprenal extract that produces its pressor effects was isolated by the joint research of John Abel in 1899 and Jokichi Takamine in 1901. Within three years Elliott, working in Langley's laboratory, suggested that this active principle, referred to by British physiologists as "adrenaline" and named "Adrenalin" by Takamine, was released from sympathetic nerve terminals to act on smooth muscle cells. However, it was not until 1946 that von Euler showed that demythelated adrenaline (noradrenaline) rather than adrenaline is a sympathetic transmitter. The possibility that this sympathetic transmitter could also act on nerve terminals was not developed until 1971. Research on autoreceptors culminated in the identification of adrenergic receptors on nerve terminals different to those on muscle cells. This paper assesses the contributions that established the idea of the adrenergic autoreceptor, 100 years after the discovery of adrenaline.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454061     DOI: 10.1007/bf02281628

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  48 in total

1.  A proposed dual neurohumoral role of acetylcholine: its functions at the pre- and post-synaptic sites.

Authors:  G B KOELLE
Journal:  Nature       Date:  1961-04-15       Impact factor: 49.962

2.  Evidence for the presynaptic location of the alpha-adrenoceptors which regulate noradrenaline release in the rat submaxillary gland.

Authors:  E J Filinger; S Z Langer; C J Perec; F J Stefano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

3.  Observations on the physiological action of extracts of the supra-renal bodies.

Authors:  J N Langley
Journal:  J Physiol       Date:  1901-10-16       Impact factor: 5.182

Review 4.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

5.  Characterization of alpha 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones.

Authors:  J T Williams; G Henderson; R A North
Journal:  Neuroscience       Date:  1985-01       Impact factor: 3.590

6.  The fate of 3 H-norepinephrine released from isolated atria and vas deferens: effect of field stimulation.

Authors:  S R Tarlov; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

Review 7.  Bimodal regulation of adenylate cyclase.

Authors:  D M Cooper
Journal:  FEBS Lett       Date:  1982-02-22       Impact factor: 4.124

8.  Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors.

Authors:  L Cubeddu; E M Barnes; S Z Langer; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1974-09       Impact factor: 4.030

9.  The metabolism of (3H)noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat.

Authors:  S Z Langer
Journal:  J Physiol       Date:  1970-07       Impact factor: 5.182

10.  Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine.

Authors:  S M Kirpekar; M Puig
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

View more
  3 in total

Review 1.  Bedside bleeding control, review paper and proposed algorithm.

Authors:  Richard Simman; David Reynolds; Sharon Saad
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

2.  Adrenergic stimulation alters the expression of inflammasome components and interleukins in primary human monocytes.

Authors:  Johann-Philipp Horstmann; Ingo Marzi; Borna Relja
Journal:  Exp Ther Med       Date:  2015-11-10       Impact factor: 2.447

3.  Catha edulis chewing effects on treatment of paranoid schizophrenic patients.

Authors:  Mohamed-I Kotb El-Sayed; Hatem-K Amin
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-15       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.